FDA Inspection 1106124 — Xavier Leleu, MD. Ph.D.
The FDA completed an inspection of Xavier Leleu, MD. Ph.D. on September 20, 2019 in Poitiers. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 20, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Poitiers (France)
Additional Details
Clinical Investigator (CI)